Kingsview Wealth Management’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q1
Sell
-200
Closed -$33K 944
2021
Q4
$33K Buy
+200
New +$32.7K ﹤0.01% 917
2020
Q2
Sell
-800
Closed -$3K 634
2020
Q1
$3K Buy
+800
New +$114K ﹤0.01% 475
2019
Q1
Sell
-300
Closed -$1K 506
2018
Q4
$1K Hold
300
﹤0.01% 370
2018
Q3
$1K Hold
300
﹤0.01% 396
2018
Q2
$1K Hold
300
﹤0.01% 367
2018
Q1
$1K Hold
300
﹤0.01% 353
2017
Q4
$1K Sell
300
-100
-25% -$13.9K ﹤0.01% 378
2017
Q3
$4K Sell
400
-200
-33% -$26.5K ﹤0.01% 310
2017
Q2
$2K Sell
600
-500
-45% -$63.8K ﹤0.01% 316
2017
Q1
$1K Buy
+1,100
New +$131K ﹤0.01% 289

Other funds holding JNJ

Kingsview Wealth Management's JNJ Position: Q1 2026 in Review

Kingsview Wealth Management reduced its Johnson & Johnson (JNJ) stake by 7.4% in Q1 2026, selling an estimated $1.84M and leaving 98,946 shares worth $24.2M. The position accounts for 0.33% of the portfolio, ranked #53.

Kingsview Wealth Management first reported a position in JNJ in Q1 2017 and has held it in 37 quarters since. The position peaked at $24.7M in Q3 2024. 4,616 funds tracked by Wall St. Rank hold JNJ as of Q1 2026.

  • Kingsview Wealth Management held 98,946 shares of Johnson & Johnson worth $24.2M as of Q1 2026.
  • Kingsview Wealth Management sold 7,901 Johnson & Johnson shares in Q1 2026, an estimated $1.84M.
  • Johnson & Johnson made up 0.33% of Kingsview Wealth Management's portfolio in Q1 2026, its #53 holding.
  • Kingsview Wealth Management first reported a position in Johnson & Johnson in Q1 2017 and has held it in 37 quarters since.
  • Kingsview Wealth Management's Johnson & Johnson position peaked at $24.7M in Q3 2024.
  • 4,616 funds tracked by Wall St. Rank held Johnson & Johnson as of Q1 2026.

Based on Kingsview Wealth Management's 13F filing for Q1 2026, filed 12 May 2026.